Bank of America
WST icon

Bank of America’s West Pharmaceutical WST Stock Holding History

Bank of America’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,000
Closed -$6.93M – 7978
2023
Q1 		$6.93M Buy
+20,000
New +$5.84M ﹤0.01% 3198

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's WST Position: Q1 2026 in Review

Bank of America reduced its West Pharmaceutical (WST) stake by 28% in Q1 2026, selling an estimated $37.3M and leaving 381,813 shares worth $95.7M. The position accounts for 0.01% of the portfolio, ranked #1151.

Bank of America first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $263M in Q1 2022. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Bank of America held 381,813 shares of West Pharmaceutical worth $95.7M as of Q1 2026.
  • Bank of America sold 150,033 West Pharmaceutical shares in Q1 2026, an estimated $37.3M.
  • West Pharmaceutical made up 0.01% of Bank of America's portfolio in Q1 2026, its #1151 holding.
  • Bank of America first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's West Pharmaceutical position peaked at $263M in Q1 2022.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.